Ondine Biomedical Inc. (AIM: OBI)

Ondine Biomedical Revenue

In the year 2023, Ondine Biomedical had annual revenue of 1.20M CAD with 88.56% growth. Ondine Biomedical had revenue of 775.00K in the half year ending December 31, 2023, with 30.47% growth.

• Revenue: 1.20M CAD
• Revenue Growth: +88.56%
• P/S Ratio: 17.57
• Revenue / Employee: 66.83K CAD
• Employees: 18
• Market Cap: 17.68M GBP

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.20M	565.00K	88.56%
Dec 31, 2022	638.00K	-1.93M	-75.17%
Dec 31, 2021	2.57M	778.00K	43.44%
Dec 31, 2020	1.79M	258.16K	16.84%
Dec 31, 2010	1.53M	502.61K	48.79%